Introduction
The epithelia of mammalian gastrointestinal, tracheobronchial, and genital tracts are protected by mucus secretion. Mucins are the major glycoprotein components of mucus and are synthesized by the goblet cells of the epithelia and in some cases by submucosal glands.
Mucins constitute a heterogeneous group of high molecular weight, polydisperse, highly glycosylated molecules. By electron microscopy they appear as long filaments with a wide range of lengths ranging from 200 to >lo00 nm (1-4) .
The viscous and elastic properties of the thick mucous gel present over the majority of epithelia are attributable to the polyanionic structure of mucins and to physical entanglement of mucins and other molecules. The mucus provides a selective barrier adapted to the specific physiology of each mucosa. Since many diseases affect the quality and/or quantity of the mucus and the constituent mucins, histochemists need a classification of mucins to help give an indication of normal or altered status of mucin biosynthesis. Mucins can be divided into three main classes: neutral mucins containing mainly hexoses, acidic mucins or sialomucins, and very acidic encode secreted mucins, i.e., MUC 2, 3, 4 (HGM nomenclature) and 5B, 5C (proposed name). These genes present a nucleic tandem repeat organization. The choice of oligonucleotide probes was made to amplify the signal by hybridization of many small probes on the same mRNA molecules. A characteristic pattern of mucin gene expression was observed for each muom. mucins or sulfomucins. Histochemical techniques are available that help to identify these different mucin subclasses (5) (6) (7) .
Immunologists have tried to produce antibodies raised against mucins to develop specific immunoprobes suitable for conventional immunohistochemistry (8, 9) and to approach the mucin modifications during carcinogenesis (10) . Unfortunately, most of the polyclonal and monoclonal antibodies directed against mucins recognize carbohydrate epitopes or are very difficult to classify.
Recent developments in cloning human mucin genes now enable us to approach the peptide moiety of these macromolecules either by immunohistochemistry or by in situ hybridization. Several distinct genes have been identified that encode the human mucins. MUC 1, the gene encoding "episialin" (also called PEM or PUM), a membrane 0-glycoprotein, is located on chromosome 1 (11, 12) . Episialin is present on many epithelia and is averexpressed in breast and pancreatic carcinomas. Genes coding for the secreted intestinal mucins MUC 2 and MUC 3 were mapped to chromosome 11 (p15 band) and to chromosome 7 (q22 band), respectively, using intestinal mucin cDNA probes (13) (14) (15) . Tracheobronchial mucin cDNAs were used to identlfy two more genes, MUC 4 and MUC 5, which were mapped to chromosome 3 (q29) and to chromosome 11 (p15), respectively, using probes (16) (17) (18) (19) . Since the MUC 5 cDNAs could be divided into three distinct groups of non-overlapping clones (which were in turn distinct from MUC 2). we have tentatively named these MUC 5A, 5B, and 5C. However, since all the cDNA clones described for both the respiratory (19) and intestinal mu-cins (13.14) are incomplete, one cannot exclude the possibility that a single gene on chromosome 11 p15 is expressed in both human tracheobronchial and intestinal mucosae.
Except for MUC 1, the human mucin probes each hybridize with mucin mRNAs to give very polydisperse signals on Northern blots (8, 14) . Smears on Northern blot analysis could be due to the heterogeneity of the messages produced by a single cell, by different cells within a gland, or by many other factors such as rapid turnover of the "As, artifactual degradation of large-sized mRNAs, or selective degradation of the mucin "As.
The probes in our possession were tested on mRNA from different human mucosae and only a few of them were able to recognize mucin message in all the tissues tested (20) . These results suggested cell-and tissuespecific regulation of the expression of at least some human mucin genes.
To study possible cell specificity, we performed in situ hybridization studies on human mucosae from respiratory, digestive, and reproductive tracts. Healthy areas from submaxillary gland, bronchus, fundus, antrum, jejunum, ileum, colon, and endocervix were selected. Since each of the different nucleotide sequences already published included a tandem repeat region, we used oligonucleotide probes corresponding to each characteristic tandem repeat domain of MUC 2, 3, 4, 5B, and 5C and examined the level of the expression and the cell localization of the hybridization signal given by each gene-specific mucin probe. The subsequent compilation of results enabled us to define a specific pattern of mucin expression for each tissue, thus describing the "normal" status for mucin biosynthesis.
Materials and Methods
Choice of Oligonucleotides. Since the different human mucin genes each contain regions of tandem repeats (which range in size from 24 BP for MUC 5 c (19) . 48 BP for MUC 4 (17), 51 BP for MUC 3 (14) , 69 BP for MUC 2 (13) to 87 BP for MUC 5B (21), we chose to use oligonucleotide probes corresponding to these regions for our in situ hybridization studies, instead of riboprobes. This choice was made to amplify the signal, since it should be possible to hybridize many small probes to the same mRNA molecule. Since the DNA sequences of the different mucin genes are not yet complete, we can expect at least 100 oligonucleotide probes for MUC 2 (22), seven for MUC 3 (14) . 39 for MUC 4 (17), 22 for MUC 5B (21), and 34 for MUC 5C (19) . We chose 48 BP length oligonucleotides, each of which corresponds to a different gene or region of a gene. Each probe can hybridize to one tandem repeat (or two for MUC 5C). its nucleotide sequence being complementary to the most frequently found repetitive structure. In the case of MUC 2 and MUC 3 we used the cDNA sequences published by Gum et al. (13, 14) (Table 1) . For MUC 4, MUC SB, and MUC 5C, comparison of all our cDNA sequences (17.19.21) enabled us to choose the oligonucleotide sequences indicated in Table 1 .
Preparation of Oligonucleotides. Five different 48-mer oligonucleotides were synthesized by Eurogentec (Litge, Belgium). They were purified by electrophoresis on a 20% polyacrylamide gel. The band corresponding to each 48-mer was excised and eluted in distilled water at 60°C for 40 min and overnight at room temperature (RT). The oligonucleotides were desalinized on SepPack Plus C18 cartridges (Millipore Waters; Saint Quentin en Yvelines, France) eluted by uiethylammonium acetate-methanol (vlv).
Labeling of Oligonucleotides. Fifty of each oligonucleotide was incubated with 50 pCi of a-[ 3'S]-thiodeoxyadenosine triphosphate (>lo00 Cilmmole) (Amersham; Les Ulis, France), 0.1 mM manganese chloride, 0.1 mM magnesium chloride, and 40 units of terminal desoxynucleotidyl transferase (Amersham) in 100 mM sodium cacodylate for 75 min at 37'C. The probes were then purified on a G25 Quick Spin Column (Boehringer; Mey-Ian, France).
Tissue Selection and F"sing. Samples of normal mucosae were taken from macroscopically and histologically normal margins of surgical specimens: two submaxillary glands, bronchial mucosae from four different lungs, mucosae from four different surgical specimens for each of the successive parts of the digestive tract, and 12 samples of different endocervix uteri.
The samples of normal mucosae were taken less than 5 min after surgical removal of the organ. They were immediately immersed in fresh 4% paraformaldehyde in phosphate buffer. The thickness of the samples was around 4 mm and the fixation time was limited to 4 hr. The samples were then further processed for paraffin embedding. The temperature for embedding was <56'C. Three-mm thick sections were cut under sterile conditions and put on gelatin-covered slides.
In Situ Hybridization. The protocol was first described by Guitteny and colleagues (23) and modified in our laboratory as follows. Slides were deparaffhized by two washes in xylene for 10 min each, rehydrated in 100, 70, and 30% ethanol for 5 min each, and finally washed in distilled sterile water for 5 min. After washing for 10 min in 0.1 M glycine and 0.2 M Tris-HCI, pH 7.4, the sections were incubated with a 2 pglpl proteinase K solution (Boehringer) in 0.1 M Tris-HC1, pH 8, 50 mM EDTA at 37'C for 15 min. They were then washed in distilled water for 5 min and fixed in 4% paraformaldehyde solution (PBS, pH 7.4) for 15 min at RT. The slides were then treated in 0.25% acetic anhydride, 0.1 M triethanolamine, pH 8, for 10 min at RT to reduce nonspecific binding.
The sections were washed briefly in distilled water and incubated in SSPE 4 x , Denhart's 1 x buffer for 1 hr at RT. They were then dehydrated through 30, 70, and finally 100% ethanol and dried at RT.
Twenty to 90 p1 of solution containing 3 x lo3 to 8 x lo3 dpm of 3'S-labeled oligonucleotide/ pl was applied on each section. The hybridization buffer was SSPE 4 x , 1.2 M sodium phosphate, pH 7.2, N-lauroyl sarcosine 0.1% (wlv), Denhart's 1 x , 0.5 mg/ml yeast tRNA, 20 mM dithiothreitol, 50% formamide (vlv). The sections were hybridized for 14-16 hr at 42'C in moist chambers.
Post-hybridization washings were successively performed in SSPE sohtions of decreasing concentrations: (a) SSPE 4 x , 20 mM dithiothreitol, 
5' GGT CTG TGT GCC GGT GGG TGT TGG GGT TGG GGT CAC CGT GGT GGT GGT 3'

5' GGT GGT CTC GGT GGT GGT GAT
GA AGA AGT GAA GCT GGG AGT ACT GTG 3' iz at 45°C. The sections were dehydrated in successive 30, 70, and 100% ethanol baths and air-dried. Autoradiographic detection of the hybrids was carried out by dipping in Amenham LM-1 emulsion for 3 sec. The sections were allowed to air-dry vertically for 1 hr and were then placed in a 4'C desiccation chamber for 2-3 weeks. They were developed for 3 min in Kodak D-19 developer, washed in distilled water for 1 min, and fixed for 5 min in 30% sodium thiosulfate (wlv). After washing for 1 hr in distilled water, the sections were counterstained with methyl green pyronin (Sigma; St Louis, MO).
Controls for in situ hybridization consisted of (a) prior digestion with 50 pglml of RNAse A (Boehringer), 0.4 M NaCI, 10 mM Tris-HC1, pH 7.5, 5 mM EDTA for 45 min at 37'C, (b) competition studies with a 50fold excess of unlabeled relevant and irrelevant probes, and (c) substitution of human mucosae by human muscle.
Results and Discussion
The results obtained for the different human mucosae with the different MUC probes are summarized in Table 2 . To check the quality of the different hybridization signals, we performed all the usual controls required by this technology: competition with the same unlabeled oligonucleotide, testing all the procedures on irrelevant tissues such as muscle, and stringent post-hybridization washing conditions to cancel the background.
When a positive hybridization signal was seen it was always specifically localized on epithelial cells or mucous glands known to be able to synthesize mucins. Analysis of serial sections prepared from the same paraffin block with each of the probes enabled us to compare systematically the expression of the different mucin genes.
The MUC 2 probe, as expected, gave the strongest labeling in the small and large intestine (Figures 1C and 2A) . This strong signal was observed on the goblet cells and the mucous cells of the Liberkiihn glands. However, some goblet cells were not labeled. This could reflect the cell cycle stage of these cells. In the four samples of bronchial mucosae, the MUC 2 probe labeled some goblet cells from the epithelium and the ducts of the glands. A very weak homogeneous signal was observed on each pyloric gland, even after washing for 1 hr at 4 2 T , while the MUC 2 probe did not recognize the epithelia and the glands of cardiac (one sample) and fundic (three samples) mucosae.
The MUC 3 gene was essentially expressed in the small intestine ( Figure 1D) and labeled every epithelial cell homogeneously. This signal disappeared at the beginning of the ducts of Lieberkiihn glands. A very weak signal was observed in the colonic, pyloric, and fundic mucosae (Eble 2) .
Recently, MUC 2 and MUC 3 gene expression was studied in normal and neoplastic tissues by RNA Northem and slot-blot analysis (24). The authors showed that MUC 2 and MUC 3 mRNA was highly expressed in normal jejunum, ileum, and colon compared with very low levels in normal bronchus. These results are in good agreement with ours.
With the MUC 4 probe, all the epithelia were homogeneously labeled. In bronchial mucosa (four samples) ( Figure 3B) we also observed labeling where the gland ducts reached the bronchial surface. The glandular acini and the serous glands were never labeled. In the colonic mucosa, all the epithelial cells were labeled uniformly and the glands more intensely (Figure 2B) . The same observation was made for endocervix (12 specimens; Figure 2C) .
MUC 5B was the only probe to detect all the glandular acini in submaxillary glands (two samples). The labeling was of intermediate intensity ( Figure 3A) .
In the four samples of bronchial mucosae, this probe recognized the mucous cells from the acini of the submucosal glands ( Figure  3C) . The serous cells and the epithelium were not labeled. However, some goblet cells were weakly labeled after long exposure (3 weeks) .
MUC 5C could be characterized as a gene expressed in the respiratory and gastric tracts. In bronchial mucosae, MUC 5C failed to label the glandular acini in any of the samples (Figure ID) . In three cases the epithelia and the outflow of the gland ducts of in- trapulmonary bronchi were strongly labeled. However, this labeling was less homogeneous than with the MUC 4 probe, and only goblet cells were labeled. In one case the primary bronchi showed no labeling either on the acini or the epithelium. This was not due to the quality of the specimen, since other the probes were positive on the same block. It could be due to an interindividual variation or to the differentiation stage of these epithelial cells in relation to the different position in the respiratory tree. Figure 1A shows the very strong signal obtained with the MUC 5C probe in the fundic mucosae. This basal labeling was localized on all the epithelial ceUs and the glandular crypts. In the pyloric mucosa the MUC 5C probe gave a strong basal signal on every epithelial cell but not on the gland (Figure 1B) .
The MUC 5C probe also gave an intermediate labeling on the epithelium and the glands of endocervical specimens ( Figure 2D) .
The probes corresponding to MUC 4,5B, and 5C were obtained from an airway mucosa cDNA library. Howcver, MUC 4 and 5C could be considered as encoding mucins synthesized by epithelial chial mucosa: labeling of superficial epithelial cells with chial mucosa: labeling of some epithelial cells with MUC cells, whereas MUC 5B could be essentially synthesized by glandular acini in the respiratory tract.
The combined results described above indicate that a single mucin gene cannot act as marker for one type of mucosa. Several d8er-ent MUC genes are expressed within a single mucosa by either the same or different cells of the epithelia or glands. The signal intensity may also vary from individual to individual, since extensive polymorphism has been described for all of the mucin genes stud-ied. The number of tandem repeats expressed can vary considerably, and more or less of each probe may hybridize to the same mRNA molecule.
It is very difficult to compare the labeling intensity obtained by Northern blot analysis and by in situ hybridization. In the first case the studies were done on small surgical fragments and the signal would have been ''diluted'' by the presence of many non-secreting cells. In contrast, the in situ hybridization studies allowed a more accurate assignment ofthe cells able to synthesize one or more mucin families. A good example is the colonic mucosa, where MUC 2 gave a very strong signal on some goblet cells whereas MUC 4 labeled all the epithelial cells weakly. This kind of difference is not detectable by Northern blot analysis because the signal obtained will have the same intensity.
Oligonucleotide probes are good tools to study mucin expression because each sequence described contains a region with tandem repeat organization. However, we have prepared some riboprobes, in particular for MUC .5B and MUC 5C, which contain fewer conserved tandem repeats. The results obtained with these probes have not shown significant differences from the oligonucleotide probes, which are easier to use.
Previous histological studies involved detection of the carbohydrate components of the mucins by histochemistry, immunohistochemistry, and lectin-binding characteristics. To date, no specific relationship is known between particular carbohydrate structures and the mucin peptides expressed by each gene. The new tools in our possession will help to identify the peptide moiety of mucins and the genes expressed. This approach should provide a useful tool for the characterization of disorders of mucin biosynthesis in various human diseases. A combination of immunohistochemistry and in situ hybridization studies may help in the diagnosis and prognosis of certain epithelial disorders.
